Prana Biotechnology (NASDAQ: PRAN) today announced its business strategy to accelerate development of its lead asset, PBT2.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE